Treatment of incontinence

Details Treatment of incontinence Treatment of incontinence

1995-04-20

1998-04-28

Raymond, Richard L.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514365, 514438, 514471, 514649, 514651, A61K 31135, A61K 3134, A61K 3138, A61K 3144

Patent

active

057444749

ABSTRACT:
Urinary incontinence in humans is treated by administration of venlafaxine or a compound chosen from a series of aryloxy propanamines.

REFERENCES:
patent: 4314081 (1982-02-01), Molloy et al.
patent: 4761501 (1988-08-01), Husbands et al.
patent: 4956388 (1990-09-01), Robertson et al.
patent: 5023269 (1991-06-01), Robertson et al.
patent: 5192751 (1993-03-01), Thor
patent: 5250571 (1993-10-01), Fuller et al.
patent: 5281624 (1994-01-01), Gehlert et al.
Springer, et al., J. Urology, 152, 515-519 (1994).
Mesaros, et al., J. Am. Acad. Child Adolesc. Psychiatry, 32, 877-878 (1993).
Ambrosini, et al., J. Am. Acad. Child Adolesc. Psychiatry, 32, 483-493 (1993).
Michael R. Trimble, J. Clin. Psychiatry, 51, 51-54 (1990).
G. Beaumont, J. Int. Med. Res., 1, 435-437 (1973).
Wong, et al., Neuropsychopharmacology, 8, 23-33 (1993).
Foreman, M.M., and McNulty, A.M., Life Sciences, 53, 193-200 (1993).
Mesaros, J.D., J. Am. Acad. Child Adolesc. Psychiatry, 32, 877-878 (1993).
Wong et al., J. Pharmacology and Experimental Therapeutics, 222(1), 61-65 (1982).
The Merck Manual, pp. 1639-1641, published by Merck & Co., Inc., Rahway, N.J. (1987).
Rushton, J. Pediatrics, 114(2), 691-696 (1989).
Shaffer et al., Neuropharm., 18, 33 (1979).
Lipshultz et al., Invest. Urology, 11, 182 (1973).
Khanna et al., Urology, 6, 48 (1975).
Zerbe et al., J. Pharmacol. Ex. Ther., 232(1), 139-143 (1985).
Bertilsson et al., Clin. Pharmacol. Ther., 40(3), 261-267 (1986).
Cohen et al., J. Pharmacol. Exp. Ther., 248(3), 1063-1068 (1989).
Goodman et al., Pharmacological Basis of Therapeutics 7th ed., Macmillan Pub. Co., New York, pp. 85 and 422 (1985).
Thor et al., Dev. Brain Res., 54, 35-42 (1990).
Kiminao Mizukawa, Anat. Anz., 147, 125-144 (1980).
Espey, Soc. for Neuroscience Abst., 17, 1003 (1991).
Rajaofetra, J. Comp. Neurol., 318, 1-17 (1992).
Kojima et al., Cell Tissue Res., 229, 23-36 (1983).
Rasmussen, et al., Synapse, 5, 325-332 (1990).
Kojima et al., Cell Tissue Res., 226, 477-491 (1982).
Ryall, Brain Res., 37, 345-47 (1972).
Roberts et al., Br. J. Pharmacol., 95, 437-48 (1988).
White et al., Brain Res., 188, 119-27 (1980).
McMahon et al., Brain Res., 234, 237-249 (1982).
Kojima et al., Histochemistry, 81, 237-41 (1984).
Maggi et al., J. Pharmacol. Exp. Ther., 248, 278-85 (1989).
Espey et al., Eur. J. Pharmacol., 221, 167-70 (1992).
White et al., Prog. Brain Res., 88, 343-50 (1991).
Birder et al., Soc. for Neuroscience Abst., 19, 51.15 (1993).
Bux et al., Ann. Hematol., 63, 249-252 (1991).

Affiliated with

Also associated with

Rating

Treatment of incontinence does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of incontinence, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of incontinence will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1532166